Results 181 to 190 of about 53,966 (229)

Overcoming the sorafenib resistance mechanism in FLT3-mutated acute myeloid leukemia: molecular basis and new targets. [PDF]

Front Oncol
Peng H, Li M, Peng YY, Li XL, Yang J, Sun QG, Song K.   +6 more
europepmc   +1 more source

Design, synthesis, and biological evaluation of KA7, a novel quinolone-based sorafenib analogue with potent anticancer and immunomodulatory activities. [PDF]

RSC Adv
Abuarqoub D, Alshaikh A, Mohammad M, Khalaf H, Albaz N, Hmedat A.   +5 more
europepmc   +1 more source

Therapeutic potential of CDK8 inhibitor combined with sorafenib for hepatocellular carcinoma: mechanistic insights and in vitro validation. [PDF]

Eur J Med Res
Gao L, Wu H, Du SY, Lv ZL.
europepmc   +1 more source

Rottlerin triggers dual degradation of SLC7A11 and GPX4 to drive ferroptosis and chemosensitization in hepatocellular carcinoma. [PDF]

Cell Death Discov
Luo H, Jin X, Gao C, Deng Q, Han L, Hu F, Tong R, Li D, Yang H, Bian X.   +9 more
europepmc   +1 more source

Deuterium modification of tyrosine kinase inhibitors contributes to reversing ferroptosis resistance through upregulation of aldehyde oxidase 1 in hepatocellular carcinoma. [PDF]

Acta Pharm Sin B
Ma Y, Yi C, Cai N, Tao B, Geng Y, Shao W, Sun R, Chen Z, Li Y, Zhang B, Wang X, Lin J, Zhu W, Lu L, Zhang W, Chen J.   +15 more
europepmc   +1 more source

RETRACTION: Ivermectin Synergizes Sorafenib in Hepatocellular Carcinoma via Targeting Multiple Oncogenic Pathways. [PDF]

Pharmacol Res Perspect
europepmc   +1 more source

Expression and prognostic importance of lymphocyte activation gene 3 and CD73 in advanced or metastatic hepatocellular carcinoma. [PDF]

J Int Med Res
Ayhan M, Dogan A, Keser SH, Başak K, Akdeniz N, Atci MM, Erhan SS, Arikan R, Celikel C, Turan N, Yıldırım ME, Odabas H, Yıldırım S, Laçin Ş, Kostek O.   +14 more
europepmc   +1 more source

Resistance of first-line targeted drugs in hepatocellular carcinoma: the epigenetic regulation mechanisms. [PDF]

Cell Death Dis
Qi D, Qin Y, Zhu H, Li Y, Han S.
europepmc   +1 more source

Research Progress on the Molecular Mechanism of Metformin Regulating AMPK Signaling Pathway in Inhibiting Liver Cancer. [PDF]

Onco Targets Ther
Zhang HB, Yan Y, Pang JP, Kong MT, Zhu QK.   +4 more
europepmc   +1 more source